Explore the implications of optimizing cancer drug dosages on costs, patient care, and the pharmaceutical industry in this in-depth analysis of ongoing research and challenges.

Discover how Medicare coverage for NeoGenomics' RaDaR ST assay enhances cancer treatment monitoring and patient management options.

Explore Dr. Andrew Hsieh's groundbreaking work in cancer research at Fred Hutch, supported by the Gordons' endowment for innovative cancer treatments.

Discover the new scalp cooling service for chemotherapy patients at WVU Cancer Institute, improving their comfort and reducing hair loss during treatment.

Explore the strategic collaboration between Shilpa Medicare and Orion Corporation to launch a nivolumab biosimilar, enhancing access to cancer treatments in Europe.

Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.

Explore study findings on Medicare Advantage beneficiaries and their access to cancer care, reflecting on network adequacy and the need for value-based models.

Discover disparities in oncology network access between Medicare Advantage and Traditional Medicare. Learn how limited networks affect cancer treatment access.

Explore how innovative blood tests like Galleri could transform cancer screening practices and insurance coverage in the U.S. early detection strategies.

Discover Malaysia's first reinsurance treaty for Cancer Precision Medicine, improving access to innovative oncology solutions and healthcare collaborations in Southeast Asia.